Cargando…
In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease
Limited data are available regarding the in vitro activity of clofazimine against nontuberculous mycobacteria (NTM) or on outcomes of clofazimine-containing regimens in NTM-pulmonary disease (PD). Therefore, we evaluated the in vitro activity of clofazimine and the clinical outcomes of clofazimine-c...
Autores principales: | Kim, Dae Hun, Kim, Bo-Guen, Kim, Su-Young, Huh, Hee Jae, Lee, Nam Yong, Koh, Won-Jung, Kim, Hojoong, Kwon, O Jung, Jhun, Byung Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509216/ https://www.ncbi.nlm.nih.gov/pubmed/34640599 http://dx.doi.org/10.3390/jcm10194581 |
Ejemplares similares
-
The lung microbiota in nontuberculous mycobacterial pulmonary disease
por: Kim, Bo-Guen, et al.
Publicado: (2023) -
Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
por: Kim, Bo-Guen, et al.
Publicado: (2020) -
Antibiotic Maintenance and Redevelopment of Nontuberculous Mycobacteria Pulmonary Disease after Treatment of Mycobacterium avium Complex Pulmonary Disease
por: Zo, Sungmin, et al.
Publicado: (2022) -
Surgical Treatment of Pulmonary Diseases Due to Nontuberculous Mycobacteria
por: Koh, Won-Jung, et al.
Publicado: (2008) -
Genetic Analysis of Korean Adult Patients with Nontuberculous Mycobacteria Suspected of Primary Ciliary Dyskinesia Using Whole Exome Sequencing
por: Cho, Eun Hye, et al.
Publicado: (2021)